NFA
CYTK icon

Nationwide Fund Advisors’s Cytokinetics CYTK Stock Holding History

Nationwide Fund Advisors’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-66,447
Closed -$963K – 534
2017
Q3 		$963K Hold
66,447
– – ﹤0.01% 1809
2017
Q2 		$804K Buy
66,447
+47,080
+243% +$654K ﹤0.01% 1910
2017
Q1 		$249K Sell
19,367
-1,431
-7% -$16.7K ﹤0.01% 2486
2016
Q4 		$253K Sell
20,798
-1,234
-6% -$13.1K ﹤0.01% 2499
2016
Q3 		$202K Hold
22,032
– – ﹤0.01% 2614
2016
Q2 		$209K Hold
22,032
– – ﹤0.01% 2591
2016
Q1 		$155K Sell
22,032
-461
-2% -$3.37K ﹤0.01% 2640
2015
Q4 		$235K Buy
22,493
+715
+3% +$7.01K ﹤0.01% 2466
2015
Q3 		$146K Sell
21,778
-74,350
-77% -$507K ﹤0.01% 2727
2015
Q2 		$646K Sell
96,128
-36,539
-28% -$240K ﹤0.01% 2106
2015
Q1 		$899K Buy
132,667
+105,539
+389% +$788K ﹤0.01% 1939
2014
Q4 		$217K Hold
27,128
– – ﹤0.01% 2589
2014
Q3 		$95K Buy
27,128
+471
+2% +$1.98K ﹤0.01% 3000
2014
Q2 		$127K Buy
26,657
+2,552
+11% +$15.6K ﹤0.01% 2950
2014
Q1 		$229K Buy
24,105
+3,360
+16% +$30.4K ﹤0.01% 2432
2013
Q4 		$135K Sell
20,745
-462
-2% -$3.04K ﹤0.01% 2846
2013
Q3 		$161K Buy
+21,207
New +$227K ﹤0.01% 2768

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Nationwide Fund Advisors's CYTK Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Cytokinetics (CYTK) in Q4 2017, closing a stake of 66,447 shares — an estimated $963K sold.

Nationwide Fund Advisors first reported a position in CYTK in Q3 2013 and held it in 17 quarters. The position peaked at $963K in Q3 2017. 134 funds tracked by Wall St. Rank hold CYTK as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Cytokinetics position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 66,447 Cytokinetics shares in Q4 2017, an estimated $963K.
  • Nationwide Fund Advisors first reported a position in Cytokinetics in Q3 2013 and held it in 17 quarters.
  • Nationwide Fund Advisors's Cytokinetics position peaked at $963K in Q3 2017.
  • 134 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.